TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025

349 Views24 Feb 2025 19:00
Issuer-paid
On December 23, 2024, Tonix Pharmaceuticals Holding Corp. (TNXP) announced that the FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal...
What is covered in the Full Insight:
  • Business Update
  • PDUFA Date for TNX-102 SL
  • Financial Status
  • Clinical Trials and Market Potential
  • Risk Assessment
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 11-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025
    24 Feb 2025
x